Article Information
PubMed
Print ISSN
Online ISSN
History
- Received January 10, 2022
- Accepted November 21, 2022
- Published online April 21, 2023.
Article Versions
- Earlier version (January 10, 2023 - 12:50).
- Earlier version (February 17, 2023 - 13:37).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2023 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license.
Author Information
- Charlotte A. Hoogstraten,
- Jonathan J. Lyon,
- Jan A.M. Smeitink,
- Frans G.M. Russel, and
- Tom J.J. Schirris
- Department of Pharmacology and Toxicology, Radboud Institute for Molecular Life Sciences (C.A.H., F.G.M.R., T.J.J.S.), Radboud Center for Mitochondrial Medicine (C.A.H., J.A.M.S., F.G.M.R., T.J.J.S.), and Department of Pediatrics (J.A.M.S.), Radboud University Medical Center, Nijmegen, The Netherlands; GlaxoSmithKline, Safety Assessment, Ware, Hertfordshire, United Kingdom (J.J.L.); and Khondrion BV, Nijmegen, The Netherlands (J.A.M.S.)
- John Schuetz, ASSOCIATE EDITOR
- Address correspondence to:
F.G.M. Russel, Department of Pharmacology and Toxicology, Radboud University Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands. E-mail: Frans.Russel{at}Radboudumc.nl